Page last updated: 2024-08-26

bosentan anhydrous and Cardiac Remodeling, Ventricular

bosentan anhydrous has been researched along with Cardiac Remodeling, Ventricular in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bresser, P; Kloek, JJ; Marcus, JT; Reesink, HJ; Surie, S; van der Plas, MN; Vonk-Noordegraaf, A1
Bauer, Y; Bortolamiol, C; Cattaneo, C; Clozel, M; Delahaye, S; Freti, D; Hadana, H; Hess, P; Iglarz, M; Landskroner, K; Nayler, O; Renault, B; Rey, M; Schläpfer, M; Steiner, P; Studer, R; Vercauteren, M; Vezzali, E; Wanner, D; Weber, E; Whitby, BR1
He, JG; Tan, XY1
Brás-Silva, C; Correia-Pinto, J; Faria, B; Henriques-Coelho, T; Leite-Moreira, AF; Lourenço, AP; Roncon-Albuquerque, R; Wieland, J1
Hirata, Y; Yoshimoto, T1
Brower, GL; Gardner, JD; Janicki, JS; Murray, DB1
Goldstein, S; Mishima, T; Sabbah, HN; Sharov, VG; Suzuki, G; Tanimura, M; Todor, A1
Attramadal, H; Clausen, OP; Grøgaard, HK; Oie, E; Yndestad, A; ØIje, E1

Reviews

1 review(s) available for bosentan anhydrous and Cardiac Remodeling, Ventricular

ArticleYear
[Bosentan for treatment of heart failure].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, May-28, Volume: 65 Suppl 5

    Topics: Animals; Antihypertensive Agents; Bosentan; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Hypertension, Pulmonary; Sulfonamides; Ventricular Remodeling

2007

Trials

1 trial(s) available for bosentan anhydrous and Cardiac Remodeling, Ventricular

ArticleYear
Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.
    Clinical cardiology, 2013, Volume: 36, Issue:11

    Topics: Aged; Antihypertensive Agents; Bosentan; Endarterectomy; Exercise Test; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Netherlands; Pilot Projects; Pulmonary Embolism; Recovery of Function; Single-Blind Method; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Waiting Lists

2013

Other Studies

6 other study(ies) available for bosentan anhydrous and Cardiac Remodeling, Ventricular

ArticleYear
Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
    Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:5

    Topics: Animals; Bleomycin; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Gene Expression Regulation; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Pulmonary Artery; Pyrimidines; Rats, Wistar; Sulfonamides; Time Factors; Vascular Remodeling; Ventricular Function, Right; Ventricular Remodeling

2015
The remodeling of connexin in the hypertrophied right ventricular in pulmonary arterial hypertension and the effect of a dual ET receptor antagonist (bosentan).
    Pathology, research and practice, 2009, Volume: 205, Issue:7

    Topics: Animals; Bosentan; Connexin 43; Disease Models, Animal; Endothelin Receptor Antagonists; Gap Junctions; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Microscopy, Confocal; Microscopy, Electron; Monocrotaline; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Sulfonamides; Ventricular Remodeling

2009
Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:4

    Topics: Angiotensinogen; Animals; Antihypertensive Agents; Bosentan; Cytochrome P-450 CYP11B2; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Myocardial Contraction; Natriuretic Peptide, Brain; Neurotransmitter Agents; Peptides, Cyclic; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; RNA, Messenger; Sulfonamides; Ventricular Function; Ventricular Remodeling

2006
Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:3

    Topics: Animals; Antihypertensive Agents; Bosentan; Collagen; Cytokines; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Heart; Male; Mast Cells; Matrix Metalloproteinases; Myocardium; Myofibrils; Rats; Rats, Sprague-Dawley; Sulfonamides; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling

2008
Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Journal of the American College of Cardiology, 2000, Volume: 35, Issue:1

    Topics: Animals; Antihypertensive Agents; Bosentan; Disease Progression; Dogs; Heart Failure; Infusions, Intravenous; Myocardium; Stroke Volume; Sulfonamides; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2000
Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats.
    Scandinavian cardiovascular journal : SCJ, 2002, Volume: 36, Issue:2

    Topics: Animals; Apoptosis; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Gene Expression Regulation; Heart Failure; Male; Myocardial Ischemia; Myocardium; Rats; Rats, Wistar; Sulfonamides; Ventricular Remodeling

2002